Alzamend Neuro Inc (NYSE: ALZN) — Healthcare · Share Price, Chart & Market Data
About: Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.11 (-1.77%)
ALZNAlzamend Neuro Inc
Loading watchlist status…
Trade ALZN now
Alzamend Neuro Inc share price
ALZN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:38 am GMT+0
ALZN price performance
3.738%
5D
5.714%
1M
-41.579%
YTD
-81.37%
1Y
ALZN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:38 am GMT+0
ALZN details
ALZN Market Signals